Vaccine Shows Some Promise Against Advanced Cancers
People with highest levels of dietary nitrite had nearly a 30 percent increase in risk, study shows Source: General Cancer News Articles Provided by Cancer Compass
Posts Tagged Advanced
Vaccine Boosts Survival for Men With Advanced Prostate Cancer: Study
But tests on mice needed first, researchers say Source: General Cancer News Articles Provided by Cancer Compass
Jevtana Approved for Advanced Prostate Cancer
When disease continues to worsen after treatment with standard drug Source: General Cancer News Articles Provided by Cancer Compass
Tailored Treatment for Advanced Lung Cancer?
Patients with certain genetic profile respond better to the drug Iressa than to standard chemo, study found Source: General Cancer News Articles Provided by Cancer Compass
New Study Indicates Significant Improvement In Progression-Free Survival For Patients With Advanced Pancreatic Neuroendocrine Tumors
Groundbreaking studies will be presented at the ESMO 12th World Congress on Gastrointestinal Cancer next week in Barcelona, Spain, including exciting new data on treatment for neuroendocrine tumors. Source: General Cancer News Articles Provided by Cancer Compass
Novel Paclitaxel Formulation Encouraging For Treating Advanced Lung Cancer
The June edition of the Journal of Thoracic Oncology features a study aimed at determining the optimal dose of the chemotherapy drug nab- paclitaxel with carboplatin as a first-line therapy in patients with non-small cell lung cancer (NSCLC). Results will provide researchers . Source: General Cancer News Articles Provided by Cancer [...]
FDA Approves New Treatment For Advanced Prostate Cancer
The U.S. Food and Drug Administration today approved Jevtana (cabazitaxel), a chemotherapy drug used in combination with the steroid prednisone to treat men with prostate cancer. Jevtana is the first treatment for advanced, hormone-refractory, prostate cancer that has worsened during or after treatment with docetaxel, a commonly used [...]
Tumor-Targeted Rexin-G Prolongs Survival In Gemcitabine-Resistant Metastatic Pancreas Cancer In Advanced Phase I And II Studies ASCO 2010
Epeius Biotechnologies Corporation (www.epeiusbiotech.com) announces the results of the clinical study entitled Phase I and II Studies of Intravenous Rexin-G as Monotherapy for Gemcitabine-resistant Metastatic Pancreas Cancer at the ASCO Annual Meeting on June 6, 2010. The presentation will be discussed by Dr. Howard W. Bruckner, Bruckner Oncology, [...]
Lilly Presents New Data In Advanced Melanoma – A Difficult-To-Treat Cancer That Causes Majority Of Skin Cancer Deaths
Lilly released results today from a Phase II study evaluating Lilly Oncology’s tasisulam, a novel anti-cancer agent, in patients with metastatic melanoma, the deadliest form of skin cancer.(1) Study results will be presented during the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) held in [...]
Advanced Type of Cancer Radiation Reduces Side Effects, But Impact on Controlling Cancer Is Unclear
Advanced Type of Cancer Radiation Reduces Side Effects, But Impact on Controlling Cancer Is Unclear ROCKVILLE, Md., May 27 /PRNewswire-USNewswire/ — An advanced type of cancer radiation is more successful than traditional radiation in avoiding “dry mouth” when treating head and neck cancers, but it is unknown whether the treatment is better or worse at reducing [...]